Free Trial

InflaRx (IFRX) News Today

InflaRx logo
$1.82 -0.03 (-1.62%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$0.88 -0.94 (-51.76%)
As of 04:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IFRX Latest News

InflaRx stock logo
InflaRx (NASDAQ:IFRX) Shares Acquired by Northern Trust Corp
Northern Trust Corp boosted its position in InflaRx (NASDAQ:IFRX - Free Report) by 1,933.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 666,845 shares of the company's stock after purchasing an addi
InflaRx stock logo
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Position in InflaRx (NASDAQ:IFRX)
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its stake in InflaRx (NASDAQ:IFRX - Free Report) by 21.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 625,589 shares of the
InflaRx stock logo
FY2025 EPS Estimates for InflaRx Raised by Cantor Fitzgerald
InflaRx (NASDAQ:IFRX - Free Report) - Research analysts at Cantor Fitzgerald raised their FY2025 EPS estimates for InflaRx in a note issued to investors on Thursday, May 8th. Cantor Fitzgerald analyst S. Seedhouse now forecasts that the company will post earnings of ($0.70) per share for the year
InflaRx stock logo
Q2 Earnings Forecast for InflaRx Issued By Leerink Partnrs
InflaRx (NASDAQ:IFRX - Free Report) - Stock analysts at Leerink Partnrs decreased their Q2 2025 earnings per share (EPS) estimates for InflaRx in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst J. Schwartz now expects that the company will earn ($0.24) per share for the quar
2IFRX : Preview: InflaRx's Earnings
InflaRx stock logo
Raymond James Financial Inc. Makes New Investment in InflaRx (NASDAQ:IFRX)
Raymond James Financial Inc. bought a new position in InflaRx (NASDAQ:IFRX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 638,092 shares of the company's stock, valued at
InflaRx stock logo
InflaRx (IFRX) Projected to Post Quarterly Earnings on Wednesday
InflaRx (NASDAQ:IFRX) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-inflarx-stock/)
InflaRx stock logo
Cantor Fitzgerald Forecasts InflaRx FY2025 Earnings
InflaRx (NASDAQ:IFRX - Free Report) - Cantor Fitzgerald issued their FY2025 earnings estimates for shares of InflaRx in a report released on Tuesday, April 29th. Cantor Fitzgerald analyst S. Seedhouse expects that the company will post earnings of ($0.87) per share for the year. Cantor Fitzgerald
InflaRx stock logo
Cantor Fitzgerald Initiates Coverage on InflaRx (NASDAQ:IFRX)
Cantor Fitzgerald started coverage on InflaRx in a report on Tuesday. They set an "overweight" rating and a $10.00 price objective for the company.
InflaRx stock logo
Eversept Partners LP Has $1.22 Million Stock Position in InflaRx (NASDAQ:IFRX)
Eversept Partners LP lessened its holdings in InflaRx (NASDAQ:IFRX - Free Report) by 69.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 492,452 shares of the company's stock af
InflaRx stock logo
InflaRx (NASDAQ:IFRX) Short Interest Up 36.8% in March
InflaRx (NASDAQ:IFRX - Get Free Report) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 794,600 shares, a growth of 36.8% from the March 15th total of 581,000 shares. Based on an average daily volume of 391,800 shares, the short-interest ratio is presently 2.0 days. Approximately 1.4% of the shares of the stock are sold short.
InflaRx stock logo
Raymond James Financial Inc. Purchases Shares of 638,092 InflaRx (NASDAQ:IFRX)
Raymond James Financial Inc. acquired a new position in InflaRx (NASDAQ:IFRX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 638,092 shares of the company's stock, valued at approximately $1,576,000.
InflaRx price target raised to $10 from $7 at Guggenheim
InflaRx stock logo
Guggenheim Raises InflaRx (NASDAQ:IFRX) Price Target to $10.00
Guggenheim lifted their target price on InflaRx from $7.00 to $10.00 and gave the stock a "buy" rating in a report on Wednesday.
LifeSci Capital Remains a Hold on InflaRx (IFRX)
InflaRx stock logo
HC Wainwright Reiterates "Buy" Rating for InflaRx (NASDAQ:IFRX)
HC Wainwright reiterated a "buy" rating and issued a $8.00 price target on shares of InflaRx in a research report on Friday.
InflaRx reports Q EPS (EUR 0.78) vs (EUR 0.78) last year
InflaRx stock logo
InflaRx (NASDAQ:IFRX) Posts Quarterly Earnings Results
InflaRx (NASDAQ:IFRX - Get Free Report) issued its earnings results on Thursday. The company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.18. InflaRx had a negative net margin of 33,362.70% and a negative return on equity of 65.98%.
InflaRx stock logo
Short Interest in InflaRx (NASDAQ:IFRX) Grows By 46.2%
InflaRx (NASDAQ:IFRX - Get Free Report) was the target of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 564,700 shares, a growth of 46.2% from the February 13th total of 386,300 shares. Based on an average trading volume of 382,600 shares, the short-interest ratio is currently 1.5 days. Approximately 1.0% of the shares of the company are sold short.
InflaRx stock logo
InflaRx (IFRX) Projected to Post Earnings on Thursday
InflaRx (NASDAQ:IFRX) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.
InflaRx stock logo
HC Wainwright Reiterates Buy Rating for InflaRx (NASDAQ:IFRX)
HC Wainwright reiterated a "buy" rating and set a $8.00 price objective on shares of InflaRx in a research note on Friday.
Get InflaRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for IFRX and its competitors with MarketBeat's FREE daily newsletter.

IFRX Media Mentions By Week

IFRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IFRX
News Sentiment

1.26

1.03

Average
Medical
News Sentiment

IFRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IFRX Articles
This Week

2

2

IFRX Articles
Average Week

Get InflaRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for IFRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IFRX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners